TwitterLinkedin

Contact Us

  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Our Milestones
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Development Strategy and Gap Analysis
            • Integrated Product Development
            • Market Access
            • Non-clinical Development Concept
              and Study Design
            • Scientific Advice
            • Scientific Due Diligence
            • Statistical Services
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Orphan Drug Designation
            • Pediatric Investigation Plan (PIP)
            • Scientific Advice
            • Statistical Services
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • IMP Management
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
            • Vendor Management and Oversight
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistical Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Environmental Risk Assessment
            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • Audit and CAPA Management
            • EU QPPV / National QPPV
            • ICSR Management
            • Literature Screening
            • Pharmacovigilance Systems
            • Safety Writing (PSUR, RMP)
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • Good Distribution Practice (GDP) Compliance
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Vendor Audit
            • Vendor Management and Oversight
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
            • Medical Information
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • Consulting
            • Consumer Healthcare
            • Generics
            • Herbal Medicines
            • Medicinal Products
            • MedTech Services
            • Pharmaceutical
            • Veterinary Drugs
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • Brexit
            • COVID-19 Support
            • Drug Re-purposing / Value-added Medicines
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Statistical Services
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • News
    • Webinars
    • Events
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Working at PharmaLex
    • Your Application Process
    • Career Opportunities
  • Training
Home > Our Services > Statistical Services

Statistical Services

Confidence Beyond Compliance

PharmaLex is recognized as a global leader in the application of Bayesian methodology consulting and programming in the Biopharma industry, from pre-clinical to late phase studies and in a wide range of therapeutic areas.

Bayesian thinking is at the heart of our approach. While our team is comfortable handling classical or frequentist statistics as well as advanced Bayesian statistics, our problem-solving strategy always puts new problems into a Bayesian perspective. This provides our customers with a crystal-clear understanding of the solutions proposed, its impact and the long term opportunities.

Providing both statistical training and consulting services to pharmaceutical and biopharmaceutical companies, our goal is the same as the companies we support – to efficiently and consistently develop and deliver quality medicine to patients.

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

Discovery and Pre-clinical Research

PharmaLex has significant expertise in supporting discovery laboratories in pharmaceutical sciences with great emphasis on in-vitro and in-vivo animal models to ensure the studies are adequately reproducible and predictive to support decision making. PharmaLex applies a lifecycle vision and Quality by Design (QbD) approach for in-vitro and in-vivo assays that starts by the definition of the objectives and aims and ends with a control strategy. In between, best practice of Design of Experiments (DoE), advanced modeling and Bayesian statistics are applied to ensure reproducibility and predictability of results.

Our services include:

Statistics for the development and qualification of bioassays

  • HTS, LTS
  • Design of experiments
  • Advanced signal processing
  • Optimization and qualification
  • Parallelism assessment and determination
  • Multicriteria decision making and ranking of compounds
  • Z score, Uncertainty
  • Reproducibility evaluation
  • Transfer and comparisons
  • Control strategies

Statistics for the development of in-vivo pharmacology models

  • Design and optimization
  • Powering for reproducibility, Z score
  • Development of accurate end-points
  • Modeling to support translation to human
  • PK/PD, non-linear and Bayesian models
  • 3R methodologies and comparison
  • Historical control groups
  • Control strategies

Development of biomarkers

  • Identification of biomarkers
  • Control of FDR (False Discovery rates)
  • Evaluation of performances (Sensitivity, Specificity, ROC, NPV, PPV)
  • Development and validation of kits
  • Optimization and design of clinical trial to qualify biomarkers
  • Multiplex

Therapeutic areas

  • Immunology
  • Oncology (Xenograft models, …)
  • Metabolic disorders
  • CNS
  • Cardiology

Clinical Development

PharmaLex is specialized in the development and analyses of innovative clinical trials to maximize the probability of success and the outcome. We use a blend of expertise ranging from Bayesian statistics, pharmacometry and scientific programming to develop by means of intensive simulations cost-effective clinical trials, including adaptive designs and analyses methods. We also produced the highest quality reports (TFLs) and contribute to the study reports and publications.

Our services include:

Protocol and SAP development

  • Methodological support and contribution
  • Evaluation and optimization of clinical end-points
  • Power and optimization using Clinical trial simulations
  • Development of wide range of Adaptive designs
  • Advanced Bayesian statistics
  • Meta-analyses and MAP approaches for prior elicitation

Contribution to CSR and submission

  • Writing and review of CSR
  • Participation to meetings with regulatory bodies

Pediatric development, rare and orphan disease

  • Specialized in rare disease
  • Use of historical data
  • Development of optimized designs with limited data

Biomarker qualification

  • Expertise in bioassays
  • Advanced simulations for design optimization

Analyses of complex data and signals

  • Modeling of PET-scan
  • Modeling of EEG and ECG data

Pharmacovigilance and recruitment

  • Signal detection
  • Bayesian models for efficient Signal detection methodologies
  • Modeling and prediction of recruitment of patients

Programming

  • SAS Programming, CDISC/SDTM/ADAM
  • Production of TFLs for CSR
  • Including NCA PK reporting

JMP-Clinical

  • Training for use and development using JMP-Clinical
  • Applied Risk Based Monitoring using JMP-Clinical

Bio-Analytics

PharmaLex has a recognized and innovative expertise in the development, validation and control of analytical procedures and bioassays. We have been a pioneer in applying the Quality by Design (QbD) and lifecycle thinking to analytical procedures and bioassays with a vision: achieving confidence and compliance. Our team is composed of chemists, biologists and pharmacists that are able to provide the most advanced statistical support to ensure your analytical procedures and bioassays are reliable and compliant. Our scientific and quality team can also provide you with the automated analyses tools to maximize your productivity in accordance with regulations. Finally we also have a tremendous expertise in PAT procedure development and validation.

Our services include:

Bioassays

  • Expertise in a wide range of bioassays (ELISA, qPCR, FACS, MNA, …)
  • Development by means of DoE
  • Optimization for precision and range
  • Strategies and methods for parallelism evaluation
  • Advanced signal processing, multiplex assays
  • Non-linear modeling
  • Format optimization and justification
  • Evaluation of capability and uncertainty
  • Control strategy and transfer

Analytical procedures

  • Modeling of wide range of procedures (HPLC, MS, NIR, RAMAN, ….)
  • Development by means of DoE
  • Optimization of procedures by means of advanced modeling
  • Advanced signal processing (UV, NIR, MIR, RAMAN)
  • Validation of PAT procedures NIR and RAMAN based
  • Format optimization and justification
  • Evaluation of capability and uncertainty
  • Control strategy

Process Design and Manufacturing

PharmaLex has many years experience in proposing robust and innovative statistical solutions for the development, validation and control of processes, in particular bio-processes for mABs, vaccines and cell cultures. Combined with expertise in analytics, PharmaLex ensures that the robustness of (bio) processes is guaranteed.

Our services include:

Lifecycle and Quality by Design methodology

  • Strategies for stage 1, stage 2 and stage 3
  • Advanced Design of Experiments (DoE)
  • Computation of multi criteria Design Space
  • CPV
  • Robustness metrics and predictive capability
  • Statistical Process control
  • Strategies and report of transfer
  • Optimization and modeling of scale-up scale-down
  • Definition of specifications
  • Development and implementation of PAT methodologies

Continuous manufacturing

  • Setup and justification of sampling plan
  • Development and implementation of PAT
  • Methodologies for release testing
  • Assessment of content uniformity

Stability

  • Design of optimized stability studies
  • Computation of shelf-life
  • Internal Release Limits for linear and non-linear degradation
  • Accelerated modeling and prediction

Formulation

  • Specialized Design such as mixtures design
  • Advanced Modeling for optimization
  • Combined prediction with stability assessment

Artificial Intelligence and Data Science

PharmaLex uses state-of-the-art Artificial Intelligence (AI) and its long experience in data science to solve our specific customer’s problems, as an addition to our strategical statistical services. Our team, composed of experts from various scientific fields such as mathematics, Bayesian statistics, chemistry, bioengineering, etc., is working in close collaboration with our customer to meet their needs. At PharmaLex, we believe a multi-disciplinary team is the best way to make effective data science and support effective decision making in the pharmaceutical world.

Our healthcare expertise combined with our multidisciplinary team are used to deeply understand our customer’s very questions and envisage top-notch AI solution wherever needed. For instance, it is common to apply AI and machine learning tools on big and unstructured data contained in data lakes and other LIMS.

The PharmaLex team masters most advanced programming languages that are used in statistics and Data Science such as SAS, R, STAN, JAGS, Python, Java, C++, but also modern operating environments such as Hadoop or Tensorflow (Keras).

Our key value-added deliverable has always been in delivering fit-for-purpose modeling on which solutions are build. To ensure compliance, our statistical experts are working closely with our IT and Quality departments. It allows for example the creation of AI-powered software, that is completely compliant with regulatory environment (GAMP5, 21CFR part 11). This accumulated sum of competencies makes us one of the few being able to develop solutions in full accordance with all the (Bio-)Pharmaceutical regulation (ICH-USP-EMA). In addition, the software validation ensures that the right diagnostic or answer is provided with high confidence. For validating AI solutions, specific trials are developed to ensure fair comparison with human gold standard or other algorithmic solutions. For instance, our clinical experts can evaluate the impact of modeling/prediction uncertainty directly on the outcome of the clinical study.

As most data scientists, we started applying machine learning methodologies in applied pharmaceutical development (process, assay, etc.) using classical tools such as SVM, Random Forest, Lasso, PLS, etc. We developed predictive methodologies to evaluate model quality as the classical metrics may fail at providing the right conclusion. We stay upfront of the technology by using most recent algorithms such as Boosted Trees or by handling uncertainty in Neural Network (similar to what we do in Bayesian statistics). Computational power for handling big data in short time frame is also available.

Examples of applications

  • Survival time predictions using big cytometry database: comparison of the performance of various AI algorithms
  • Biomarkers detection on large tox datasets
  • Root cause analysis based on variable importance metrices from gradient boosting model
  • Detection of epileptic seizures
  • Automatic quantification of substances from NMR signals or full DAD-chromatogram (even unresolved !)
  • Bioprocess control based on RAMAN or NIR spectra
  • Kinetic and Dynamic models based on EEG signals
  • Chemical process control using NIR spectra
  • Statistical deconvolution from cEIF and UV data
  • Fraud detection for counterfeit drugs (but also for bank transactions…)

Data Management

PharmaLex provides a broad array of clinical data management services to support this critical phase in clinical research. We help our clients generate high-quality, accurate, and statistically sound data from clinical trials. Our advanced technologies are combined with innovative solutions to reduce complexities and accelerate the drug development to marketing.

Our experts have proven experience in the management of eCRF, ePRO, IWRS, testing & validation covering all therapeutic areas. The end-to-end solution we offer can be adapted to the needs of our clients in order to create true value.

Our services include:

Study design

  • Input in CRF design
  • Creation of annotated CRF
  • Data Management Plan (DMP)
  • Data Cleaning Plan (DCP) & Programming
  • Data Validation Plan (DVP)
  • E-Platform setup (incl. eCRF/ePRO/IWRS), testing & validation
  • Data exchange with external data sources and systems (in/out)
  • ECRF completion guidelines

Study conduct

  • E-Platform and database hosting
  • Handling reference ranges
  • Data integration
  • Data Cleaning Process
  • (Risk-based) Data Monitoring through vertical and longitudinal analysis
  • Data exports

Study close-out

  • Data reconciliation across multiple sources and systems
  • Database lock, transfer & archiving
  • Data Management Report

Statistical Solutions Software

Preparing and generating FDA-compliant reports for Method Validation, Method Transfer and Product Stability can be a time-consuming and difficult exercise.

PharmaLex statistical software is a complete solution for a more streamlined and productive laboratory.

The benefits:

  • Fully validated: Our software is 21 CFR part 11 and GAMP 5 validated.
  • Regulatory friendly: Our software is compliant with global regulatory standards, including: ICH, EP and USP.
  • Software-as-a-Service (SaaS): Access the software via the Internet. All upgrades and maintenance are handled by our administrators and published worldwide.
  • Safe data: Complete encryption, safely delete all private data from our server data at log-out
  • User friendly: Generate your report in less than 10 minutes!
  • Focused on decision-making: Extensive use of graphs and charts enhances the decision making process.
Software Login

Related News

Bayesian Approaches for Incorporating Natural History Data in Studies of Rare and Pediatric Disease
7th April 2021
PharmaLex further strengthens biostatistics services
5th October 2020
Society of Quality Assurance (SQA) Virtual Meeting and Quality College
SQA, Virtual Meeting and Quality College 2020
2nd September 2020

Related Resources

Thought Leadership

  • Why you never really validate your analytical method unless you use the total error approach (part II: Producer and Consumer risks)
  • Proposal for a Single Arm Clinical Study in Rare Disease using Bayesian Statistics
  • Bayesian Power, Assurance and Probability of success: A quick who’s who
  • Bayesian Power, Assurance and Probability of Success: Reproducibility Issues
  • New SAS solutions for Population PK Model
  • Why you never really validate your analytical method unless you use the total error approach (part I: concept)

Webinars

  • Introduction to Bayesian Methodologies in CMC
  • Bayesian Adaptive Approaches in Rare and Pediatric Disease
  • Software Suite for the Life Cycle of Analytical Methods & Bioassays: Gain Trust in your Results
  • Good Statistical Practices - Discovery to Clinical Research

Related Services

  • Bayesian Statistics
  • Custom Software Development
  • Lab Tools
  • SMARTENOVAL
  • SMARTSEELVA
  • SMARTSTABELITY
  • SMARTTRANSVAL
  • Statistical Training
  • Statistics Software Login

What our clients say

I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

Richard Blackwell
Medical Team Leader, Multi Tumor Franchise Roche Products Ltd

Able to explain technical details so non-experts can understand

US based small / virtual company
Partner
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
Tweets by @PharmaLexGLOBAL
COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

    US Biotech
    Senior QA Associate
PharmaLex
©2021 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit Logo

#AskTheExpert #TogetherBEYONDCOVID19





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

    #TogetherBEYONDCOVID19

    We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.





      Select your state:

      .
      You can unsubscribe at any time at
      data.protection@pharmalex.com

      Click here to view our Privacy Policy.

      Privacy Policy

      This can be specific information about signing up to the newsletter.

      Pellentesque lobortis, tellus at ultrices ullamcorper, lectus tellus consectetur lectus, id consequat leo quam quis eros. Mauris pellentesque tortor a augue pellentesque ultricies. Phasellus sit amet suscipit orci, vel dapibus ligula. Maecenas at pellentesque lectus, sit amet tristique felis. Integer fringilla risus ac neque mollis, at imperdiet lacus sodales. In vehicula orci sed vulputate interdum. Nunc sagittis non nunc eget sollicitudin.

      Maecenas a mattis erat. Phasellus cursus erat non nisl pulvinar ultricies. Aenean id fringilla libero. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Morbi in ultrices elit. Suspendisse egestas hendrerit est. Integer pellentesque nisl ut justo tempus, nec suscipit dolor luctus. Cras vestibulum elementum tincidunt.

      In compliance with the Spanish Law 15/1999, of Protection of Personal Data and in accordance with regulations approved by the Spanish RD 994/1999 inform you that your data will be part of a file located in Friedrichsdorf (Germany), whose ownership belongs to Pharmalex Spain S.L.U. The purpose of these data is the insertion in a potential job selection process. Inform the user that at any time may exercise their right of access, rectification, and deletion of data through email curriculum@pharmalex.com or to this postal address Pharmalex Spain. Coso 103, 50001 Zaragoza, Spain.